Results 61 to 70 of about 3,929 (111)

Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis

open access: yesТерапевтический архив, 2015
Aim. To study the clinical and laboratory efficiency and safety of different etoricoxib (ET) regimens in patients with axial spondyloarthritis (axSpA), including ankylosing spondylitis. Subjects and methods.
I Z Gaydukova, A P Rebrov
doaj  

Bone Mineral Density in Ankylosing Spondylitis

open access: yesTürk Osteoporoz Dergisi, 2003
Ankylosing Spondylitis (AS), a chronic inflammatory rheumatic disease. One of the most frequent and important complications in these patients is osteoporosis.
Bahar Çakmak, Hidayet Sarı
doaj  

Clinico-epidemiological characteristics of patients with ankylosing spondylitis: experience from a specialized rheumatology centre in Bangladesh

open access: yesThe Egyptian Journal of Internal Medicine
Background Due to limited data on Ankylosing Spondylitis patients in Bangladesh, our cross-sectional study sought to assess the clinical characteristics and disease status of individuals with Ankylosing Spondylitis in this population.
A. F. M. Mahbubul Alam   +9 more
doaj   +1 more source

Pamidronato endovenoso en espondilitis anquilosante refractaria a antiinflamatorios no esteroideos (AINES) y sulfasalazina

open access: yesAnales de la Facultad de Medicina, 2007
Objetivo: Evaluar la terapia con pamidronato, en pacientes con espondilitis anquilosante (EA) activa, con respuesta subóptima o falla a los antiinflamatorios no-esteroideos (AINES) y sulfasalazina. Diseño: Estudio clínico comparativo.
Augusto García-Poma   +5 more
doaj  

Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study. [PDF]

open access: yesSci Rep
Gentileschi S   +18 more
europepmc   +1 more source

Sex differences in pain-related biopsychosocial assessments in patients with axial spondyloarthritis. [PDF]

open access: yesArthritis Res Ther
van der Kraan YM   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy